Portfolio company
Aptimmune
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops and manufactures mucosal vaccines for the global commercial swine industry to prevent viral respiratory diseases in livestock.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
ViroVet
This company develops vaccines and antiviral drugs for livestock to control respiratory diseases and other viral infections in cattle, swine, sheep and goats.
Resilient Biotics
This company develops microbiome-derived live biotherapeutics to prevent and treat respiratory diseases in livestock and humans.
ArkVax
ArkVax develops low-cost recombinant glycoconjugate vaccines for the livestock industry to protect animals from bacterial diseases and combat antimicrobial resistance.
Baseimmune
The company develops AI-designed vaccines and antigens for pharmaceutical partners and biotech researchers to treat infectious diseases and chronic conditions in humans and animals.
Lucidome Bio
This company develops a methane vaccine for ruminant livestock to help farmers reduce agricultural greenhouse gas emissions.
Native Microbials
This company develops and manufactures species-native microbial feed supplements for farmers, pet owners, and veterinarians to improve livestock and companion animal health.
TEORA
This company develops orally delivered vaccines and biologics for aquaculture, livestock and agriculture customers to prevent diseases and enhance growth.
ArkeaBio
This company develops a vaccine to reduce methane emissions from cattle for livestock farmers and global food producers.
